Mechanism of action: classic prodrug
From a pharmacological standpoint, phthalylsulfathiazole is an inactive prodrug. For the drug to start working, it must undergo biotransformation directly within the gastrointestinal tract.
When taken orally, the molecule reaches the small intestine where its activation occurs. Phthalic acid is cleaved from the parent compound. This chemical process releases the amino group, which is critical for the antibacterial activity of all sulfonamides. As a result of this cleavage, the active pharmaceutical ingredient sulfathiazole (also known in pharmacology as norsulfazole) is formed. It is this active metabolite that exerts a bacteriostatic effect on microorganisms.
Pharmacokinetics: why the drug works only in the intestine
The main pharmacokinetic feature of Phthalazolum (as well as its group analog sulfaguanidine) is its extremely poor absorption from the gastrointestinal tract.
Unlike systemic sulfonamides, which are absorbed into the bloodstream, phthalylsulfathiazole remains within the GI lumen. It does not create high concentrations in the blood, bile, or urine. The entire dose of the drug is concentrated exclusively in the intestine, creating a stably high therapeutic concentration of the active substance there. This effectively sanitizes the intestinal tract during infectious lesions.
Side effects and safety profile
Due to the absence of significant systemic absorption, the drug has an excellent safety profile. It is considered low-toxicity.
Classic side effects typical of systemic sulfonamides (such as crystalluria, hematotoxicity, or severe systemic allergic reactions) are virtually absent when taking phthalylsulfathiazole. The drug acts locally and is excreted naturally with the intestinal contents.
Specifics of use and prescription writing
The drug is available as a powder and in 0.5 g tablets. It is administered strictly orally.
Administration guidelines:
- Dosage: 0.5 g per single dose.
- Frequency: 4–6 times daily. The high dosing frequency is due to the need to constantly maintain a high concentration of sulfathiazole in the transit environment of the intestine (the drug is continuously moving through the GI tract).
- Food intake relationship: 30–40 minutes before meals.
Prescription example for tablets: Students should remember that the prescription must indicate the Latin name of the drug in the genitive case.
```latin Rp.: Tab. Phthalazoli 0,5 D.t.d. N. 20 S. Take 1 tablet orally 4-6 times daily 30-40 minutes before meals. ```
Briefly: answers to topical questions
What is the mechanism of the bacteriostatic action of sulfathiazole at the molecular level?
The mechanism of action involves competitive antagonism with para-aminobenzoic acid (PABA) and inhibition of dihydropteroate synthase. In the small intestine, phthalic acid is cleaved from phthalylsulfathiazole, forming the active substance sulfathiazole. Due to its structural similarity to PABA, it competes with it for binding to dihydropteridine. This leads to the blockade of dihydropteroic acid formation and prevents the synthesis of dihydrofolic acid by the bacterial cell.
What are the main clinical indications for prescribing phthalylsulfathiazole?
Sources confirm that phthalylsulfathiazole belongs to sulfonamides acting within the intestinal lumen. It is poorly absorbed from the GI tract and creates a high concentration in the intestine. In the small intestine, phthalic acid is cleaved from the drug, resulting in the formation of the active substance sulfathiazole. The drug is used 4–6 times daily; it has low toxicity, and side effects are virtually absent.
With which medicinal products does phthalylsulfathiazole exhibit pharmacodynamic antagonism?
Phthalylsulfathiazole exhibits chemical antagonism with local anesthetics that are derivatives of para-aminobenzoic acid (PABA) esters. These drugs include:
- Procaine (novocaine) — upon hydrolysis, it releases PABA, which acts as a competitive antagonist of sulfonamides.
- Benzocaine (anesthesine) — also releases PABA upon hydrolysis, which competes with sulfonamides.
The released PABA neutralizes the antimicrobial effect of sulfonamides. At the same time, anesthetics of other groups (e.g., lidocaine) do not form PABA during metabolism and do not reduce the antimicrobial activity of the drug.
PHTHALylsulfathiazole: in the intestine, it loses PHTHALic acid to become active sulfathiazole.
Class and exam questions
Does phthalylsulfathiazole create a high concentration in urine or bile?
No. The drug is characterized by poor absorption from the GI tract, so it does not enter the systemic circulation and does not accumulate in urine or bile. A high concentration is created only in the intestinal lumen.
Which sulfonamide drug is completely analogous to phthalylsulfathiazole in mechanism?
A complete analog in terms of mechanism and site of action is sulfaguanidine (sulgin). It also acts exclusively within the intestinal lumen.
Why must the drug be taken so frequently (4–6 times daily)?
Since the drug is not absorbed and acts locally, it continuously moves through the GI tract and is excreted with feces. Frequent administration is necessary to maintain a continuous high concentration of the active substance in the intestine.
What else to study on this topic
- General mechanism of action of sulfonamides (competitive antagonism with para-aminobenzoic acid).
- Comparison of pharmacokinetics between enteric sulfonamides and systemic drugs.
- Topical sulfonamides in other fields (e.g., sulfacetamide in ophthalmology).
- Indications for the use of enteric antibacterial agents in modern clinical practice.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Phthalylsulfathiazole" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.